Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Non-cash Items (2018 - 2025)

Bicycle Therapeutics (BCYC) has disclosed Non-cash Items for 8 consecutive years, with $6.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-cash Items rose 30.0% year-over-year to $6.6 million, compared with a TTM value of $6.6 million through Sep 2025, up 30.0%, and an annual FY2024 reading of $9.6 million, up 109.56% over the prior year.
  • Non-cash Items was $6.6 million for Q3 2025 at Bicycle Therapeutics, up from $2.7 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $207.0 million in Q4 2021 and bottomed at $2.0 million in Q1 2021.
  • Average Non-cash Items over 5 years is $33.9 million, with a median of $6.0 million recorded in 2025.
  • The sharpest move saw Non-cash Items surged 6763.47% in 2021, then plummeted 97.1% in 2023.
  • Year by year, Non-cash Items stood at $207.0 million in 2021, then tumbled by 65.7% to $71.0 million in 2022, then plummeted by 69.13% to $21.9 million in 2023, then crashed by 56.39% to $9.6 million in 2024, then plummeted by 30.8% to $6.6 million in 2025.
  • Business Quant data shows Non-cash Items for BCYC at $6.6 million in Q3 2025, $2.7 million in Q2 2025, and $6.0 million in Q1 2025.